Dual therapy with SGLT2 inhibitor and GLP-1 receptor agonist

Research studies on Dual therapy with SGLT2 inhibitor and GLP-1 receptor agonist - conditions it treats, mechanisms of action, and clinical outcomes from peer-reviewed literature.